24 results on '"Blokhina, Elena"'
Search Results
2. Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV.
- Author
-
Bertholet N, Saitz R, Hahn JA, Heeren TC, Emenyonu NI, Freiberg M, Winter MR, Kim TW, Magane KM, Lloyd-Travaglini C, Fatch R, Bryant K, Forman LS, Rateau L, Blokhina E, Muyindike WR, Gnatienko N, and Samet JH
- Subjects
- Female, Humans, HIV, Cross-Sectional Studies, CD4 Lymphocyte Count, Uganda epidemiology, Viral Load, Alcoholism, HIV Infections diagnosis, HIV Infections epidemiology
- Abstract
Background: Alcohol use has been linked to worse human immunodeficiency virus (HIV) immunologic/virologic outcomes, yet few studies have explored the effects of alcohol use disorder (AUD). This study assessed whether AUD severity is associated with HIV viral suppression and CD4 count in the three cohorts of the Uganda Russia Boston Alcohol Network for Alcohol Research Collaboration on HIV/AIDS (URBAN ARCH) Consortium., Methods: People with HIV (PWH) in Uganda (n = 301), Russia (n = 400), and Boston (n = 251), selected in-part based on their alcohol use, were included in analyses. Logistic and linear regressions were used to assess the cross-sectional associations between AUD severity (number of DSM-5 diagnostic criteria) and (1) HIV viral suppression, and (2) CD4 count (cells/mm
3 ) adjusting for covariates. Analyses were conducted separately by site., Results: The proportion of females was 51% (Uganda), 34% (Russia), and 33% (Boston); mean age (SD) was 40.7 (9.6), 38.6 (6.3), and 52.1 (10.5), respectively. All participants in Uganda and all but 27% in Russia and 5% in Boston were on antiretroviral therapy. In Uganda, 32% met criteria for AUD, 92% in Russia, and 43% in Boston. The mean (SD) number of AUD criteria was 1.6 (2.4) in Uganda, 5.6 (3.3) in Russia, and 2.4 (3.1) in Boston. Most participants had HIV viral suppression (Uganda 92%, Russia 57%, Boston 87%); median (IQR) CD4 count was 673 (506, 866), 351 (201, 542), and 591 (387, 881), respectively. In adjusted models, there were no associations between AUD severity and HIV viral suppression: adjusted odds ratios (AOR) (95%CI) per 1 additional AUD criterion in Uganda was 1.08 (0.87, 1.33); Russia 0.98 (0.92, 1.04); and Boston 0.95 (0.84, 1.08) or CD4 count: mean difference (95%CI) per 1 additional criterion: 5.78 (-7.47, 19.03), -3.23 (-10.91, 4.44), and -8.18 (-24.72, 8.35), respectively., Conclusions: In three cohorts of PWH, AUD severity was not associated with HIV viral suppression or CD4 count. PWH with AUD in the current era of antiretroviral therapy can achieve virologic control., (© 2023 The Authors. Alcohol: Clinical and Experimental Research published by Wiley Periodicals LLC on behalf of Research Society on Alcohol.)- Published
- 2023
- Full Text
- View/download PDF
3. Correlates of Intersectional HIV and Substance Use Stigma Affecting People with HIV and Substance Use in St. Petersburg, Russia.
- Author
-
Lodi S, Rossi SL, Bendiks S, Gnatienko N, Lloyd-Travaglini C, Vetrova M, Toussova O, Bushara N, Blokhina E, Krupitsky E, Ekstrand ML, Lioznov D, Samet JH, and Lunze K
- Subjects
- Humans, Social Stigma, Russia epidemiology, Substance Abuse, Intravenous complications, Substance Abuse, Intravenous epidemiology, Substance Abuse, Intravenous psychology, HIV Infections psychology, Substance-Related Disorders epidemiology, Substance-Related Disorders complications, Alcoholism complications
- Abstract
People with HIV (PWH) who inject drugs often experience coexisting HIV- and substance use-related stigma manifestations. We assessed correlates of HIV stigma (Berger HIV stigma scale), substance use stigma (Substance Abuse Self-stigma scale) and intersectional HIV and substance use stigma in a cohort of PWH with a lifetime history of drug use in St. Petersburg, Russia. Intersectional stigma was defined as having a score greater than the median for both forms of stigma. Of the 208 participants, 56 (27%) had intersectional stigma. Depressive symptoms and alcohol dependence were significantly associated with a higher HIV and substance stigma score, but not with intersectional stigma. Individual and community interventions to reduce the impact of HIV stigma and substance use stigma affecting PWH who inject drugs should consider assessing and addressing mental health and unhealthy substance use. Further work with longitudinal data is needed to understand mechanisms leading to intersectional stigma., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
4. Alcohol and falls among people with HIV infection: A view from Russia and the United States.
- Author
-
Kim TW, Heeren TC, Samet JH, Bertholet N, Lloyd-Travaglini C, Winter MR, Magane KM, Gnatienko N, Bryant K, Rateau LJ, Muyindike WR, Hahn JA, Blokhina E, and Saitz R
- Subjects
- Alcohol Drinking epidemiology, Cohort Studies, Cross-Sectional Studies, Humans, Russia epidemiology, United States epidemiology, Alcoholism complications, Alcoholism diagnosis, Alcoholism epidemiology, HIV Infections complications, HIV Infections diagnosis, HIV Infections epidemiology
- Abstract
Background: Both human immunodeficiency virus (HIV) infection and alcohol use predispose to autonomic/sensory neuropathy, imbalance symptoms, and cognitive impairment-conditions associated with a greater risk of falls-yet it is unclear how to identify people with HIV (PWH) whose drinking is associated with falls. Research on alcohol and falls using the same instruments in different countries could help to specify the level of alcohol use associated with fall risk. We examined whether a consumption-based measure (the Alcohol Use Disorders Identification Test-Consumption [AUDIT-C]) and/or a symptom-based measure (DSM-5 criteria for alcohol use disorder [AUD]) are associated with sustaining a fall among PWH in St Petersburg, Russia and Boston, Massachusetts in the United States., Methods: Separate multivariate logistic regressions were used for each cohort to examine cross-sectional associations for each alcohol measure predicting fall. Potential confounders included physical functioning, depressive symptoms, and other substance use (measured with the Addiction Severity Index)., Results: A fall was reported by 35% (87/251) of the sample in Boston and 12% (46/400) in St Petersburg. Each additional AUD criterion-but not higher AUDIT-C score-was significantly associated with a fall in both Boston (odds ratio [OR] = 1.10; 95% confidence interval [CI] 1.02, 1.18) and St Petersburg (adjusted OR AOR = 1.10; 95% CI 1.02, 1.18). Heavy alcohol use (>6 drinks/occasion, any vs. none) was associated with more than twice the odds of a fall (AOR = 2.24; 95% CI 1.21, 4.13) in Boston., Conclusions: These findings suggest that while fall risk may vary by setting and population, heavy alcohol use and AUD symptom severity are potential targets for interventions to prevent falls. Studies in diverse global settings advance our understanding of the relationship between alcohol and falls in PWH., (© 2022 Research Society on Alcoholism.)
- Published
- 2022
- Full Text
- View/download PDF
5. Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial.
- Author
-
Tindle HA, Freiberg MS, Cheng DM, Gnatienko N, Blokhina E, Yaroslavtseva T, Bendiks S, Patts G, Hahn J, So-Armah K, Stein MD, Bryant K, Lioznov D, Krupitsky E, and Samet JH
- Subjects
- Adult, Alkaloids, Azocines, Benzazepines therapeutic use, Female, Humans, Male, Nicotine, Nicotinic Agonists therapeutic use, Quinolizines, Tobacco Use Cessation Devices, Varenicline therapeutic use, Alcoholism, HIV Infections complications, HIV Infections drug therapy, Smoking Cessation
- Abstract
Importance: Cigarette smoking and risky alcohol consumption co-occur and are undertreated. Nicotine receptor partial agonists and nicotine replacement therapy (NRT) treat smoking but are unproven for alcohol, and clinical trials rarely include individuals with HIV, substance use, and mental health conditions., Objective: To compare the effects on drinking and smoking of nicotinic acetylcholine receptor partial agonists varenicline and cytisine with those of NRT., Design, Setting, and Participants: This 4-group randomized, double-blinded, placebo-controlled clinical trial was conducted from July 2017 to December 2020 in St Petersburg, Russia. Included participants were 400 individuals with HIV who engaged in risky drinking (≥5 prior-month heavy-drinking days [HDDs]) and daily smoking; they were followed up for 12 months after enrollment. Data were analyzed from May 2021 through June 2022., Interventions: Participants received alcohol and tobacco counseling, 1 active medication, and 1 placebo in 1 of 4 groups: active varenicline and placebo NRT (group 1), placebo varenicline and active NRT (group 2), active cytisine and placebo NRT (group 3), or placebo cytisine and active NRT (group 4)., Main Outcomes and Measures: The primary outcome was number of prior-month HDDs at 3 months. Secondary outcomes included biochemically validated abstinence from alcohol at 3 months and smoking at 6 months., Results: Among 400 participants (263 [65.8%] men; mean [SD] age, 39 [6] years), 97 individuals (24.3%) used opioids and 156 individuals (39.1%) had depressive symptoms. These individuals had a mean (SD) CD4 count of 391 (257) cells/mm3, smoked a mean (SD) of 21 [8] cigarettes/d, and reported a mean (SD) of 9.3 (5.8) HDDs in the prior 30 days. At 3 months, the mean (SD) number of HDDs was decreased vs baseline across all groups (group 1: 2.0 [3.8] HDDs vs. 9.5 [6.1] HDDs; group 2: 2.1 [4.3] HDDs vs 9.3 [5.7] HDDs; group 3: 1.5 [3.3] HDDs vs 8.9 [5.0] HDDs; group 4: 2.4 [5.2] HDDs vs 9.6 [6.3] HDDs). There were no significant differences at 3 months between groups in mean (SD) HDDs, including group 1 vs 2 (incident rate ratio [IRR], 0.94; 95% CI, 0.49-1.79), 3 vs 4 (IRR, 0.60; 95% CI, 0.30-1.18), and 1 vs 3 (IRR, 1.29; 95% CI, 0.65-2.55). There were no significant differences at 6 months between groups in smoking abstinence, including group 1 vs 2 (15 of 100 individuals [15.0%] vs 17 of 99 individuals [17.2%]; odds ratio [OR],0.89; 95% CI, 0.38-2.08), 3 vs 4 (19 of 100 individuals [19.0%] vs 19 of 101 individuals [18.8%]; OR, 1.00; 95% CI, 0.46-2.17), and 1 vs 3 (OR, 0.79; 95% CI, 0.35-1.78). Post hoc analyses suggested lower mean (SD) HDDs (eg, at 3 months: 0.7 [1.8] HDDs vs 2.3 [4.6] HDDs) and higher alcohol abstinence (eg, at 3 months: 30 of 85 individuals [35.3%] vs 54 of 315 individuals [17.1%]) among those who quit vs continued smoking., Conclusions and Relevance: This study found that among individuals with HIV who engaged in risky drinking and smoking, varenicline and cytisine were not more efficacious than NRT to treat risky drinking and smoking but that behavior change rates were high in all groups., Trial Registration: ClinicalTrials.gov Identifier: NCT02797587.
- Published
- 2022
- Full Text
- View/download PDF
6. Hazardous Alcohol Use, Impulsivity, and HIV-Risk Behavior Among HIV-Positive Russian Patients With a History of Injection Drug Use.
- Author
-
Chavez K, Palfai TP, Cheng DM, Blokhina E, Gnatienko N, Quinn EK, Krupitsky E, and Samet JH
- Subjects
- Adult, Female, HIV Infections epidemiology, Humans, Male, Middle Aged, Needle Sharing psychology, Risk Factors, Russia epidemiology, Sexual Behavior psychology, Substance Abuse, Intravenous epidemiology, Alcoholism epidemiology, HIV Infections psychology, Impulsive Behavior, Risk-Taking
- Abstract
Background and Objectives: Previous findings on the association between hazardous drinking and HIV-risk behavior have been equivocal, varying by population and individual difference factors. This study examined associations between hazardous drinking, impulsivity, and HIV-risk behaviors among HIV-positive Russian patients with a history of injection drug use (IDU), not on antiretroviral therapy., Methods: Negative binomial regression analyses of data from a randomized controlled trial were performed (N = 241). Main independent variables were the Alcohol Use Disorders Identification Test and the Barratt Impulsiveness Scale. Outcomes were number of condomless sexual episodes (CSE; primary), number of sexual partners, and needle-sharing frequency (secondary)., Results: Hazardous drinking was positively associated with the frequency of CSE (adjusted incidence rate ratio [aIRR] = 2.16, 95% confidence interval [CI], 1.98-2.36). Moderate (aIRR = 0.51, 95% CI, 0.46-0.56) and high (aIRR = 0.66, 95% CI, 0.60-0.73) impulsivity were associated with fewer CSE compared with low impulsivity. Hazardous drinking (aIRR = 0.64, 95% CI, 0.52-0.79) and impulsivity (aIRR = 0.95, 95% CI, 0.94-0.96) were both associated with fewer sexual partners. Hazardous drinking and impulsivity were each associated with increased needle sharing. The association between hazardous drinking and number of needle-shares was strongest at higher impulsivity levels., Conclusion and Scientific Significance: Hazardous drinking may be a risk factor for CSE among HIV-positive Russian patients and may influence needle sharing. Findings contribute to our understanding of the interactive associations between hazardous drinking and impulsivity with sexual risk behaviors and needle sharing among HIV-positive Russian patients with a history of IDU. (Am J Addict 2020;00:00-00)., (© 2020 American Academy of Addiction Psychiatry.)
- Published
- 2021
- Full Text
- View/download PDF
7. Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia.
- Author
-
Gnatienko N, Freiberg MS, Blokhina E, Yaroslavtseva T, Bridden C, Cheng DM, Chaisson CE, Lioznov D, Bendiks S, Koerbel G, Coleman SM, Krupitsky E, and Samet JH
- Subjects
- Adolescent, Adult, Aged, Alcoholism mortality, Bacterial Translocation drug effects, Cardiovascular Diseases epidemiology, Disease Progression, Double-Blind Method, Female, HIV Infections mortality, Humans, Inflammation pathology, Male, Middle Aged, Placebos administration & dosage, Risk Assessment, Russia, Surveys and Questionnaires, Survival Analysis, Treatment Outcome, Young Adult, Alcoholism complications, Alcoholism therapy, Dietary Supplements, HIV Infections complications, HIV Infections therapy, Zinc administration & dosage
- Abstract
Background Russia continues to have an uncontrolled HIV epidemic and its per capita alcohol consumption is among the highest in the world. Alcohol use among HIV-positive individuals is common and is associated with worse clinical outcomes. Alcohol use and HIV each lead to microbial translocation, which in turn results in inflammation. Zinc supplementation holds potential for lowering levels of biomarkers of inflammation, possibly as a consequence of its impact on intestinal permeability. This paper describes the protocol of a double-blinded randomized placebo-controlled trial of zinc supplementation in St. Petersburg, Russia. Methods Participants (n = 254) were recruited between October 2013 and June 2015 from HIV and addiction clinical care sites, and non-clinical sites in St. Petersburg, Russia. Participants were randomly assigned, to receive either zinc (15 mg for men; 12 mg for women) or placebo, daily for 18 months. The following outcomes were assessed at 6, 12, and 18 months: (1) mortality risk (primary outcome at 18 months); (2) HIV disease progression; (3) cardiovascular risk; and (4) microbial translocation and inflammation. Adherence was assessed using direct (riboflavin) and indirect (pill count, self-report) measures. Conclusion Given the limited effectiveness of current interventions to reduce alcohol use, zinc supplementation merits testing as a simple, low-cost intervention to mitigate the consequences of alcohol use in HIV-positive persons despite ongoing drinking.
- Published
- 2018
- Full Text
- View/download PDF
8. Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia.
- Author
-
Idrisov B, Lunze K, Cheng DM, Blokhina E, Gnatienko N, Quinn E, Bridden C, Walley AY, Bryant KJ, Lioznov D, Krupitsky E, and Samet JH
- Subjects
- Adult, Alcoholism diagnosis, Anti-HIV Agents therapeutic use, Cohort Studies, Disease Progression, Female, HIV Infections blood, HIV Infections drug therapy, Humans, Male, Risk Factors, Russia, Substance Abuse, Intravenous diagnosis, Substance-Related Disorders complications, Alcoholism complications, HIV Infections complications, Substance Abuse, Intravenous complications
- Abstract
Background: Engaging people who drink alcohol or inject drugs in HIV care can be challenging, particularly in Eastern Europe. Healthcare facilities in Russia are organized by specialty; therefore linking patients from addiction care to HIV hospitals has been difficult. The HIV care cascade outlines stages of HIV care (e.g., linkage to care, prescribed antiretroviral therapy [ART], and achieving HIV viral suppression). We hypothesized that unhealthy alcohol use, injection drug use, and opioid craving are associated with unfavorable HIV care cascade outcomes., Methods: We analyzed data from a cohort (n = 249) of HIV-positive Russians who have been in addiction hospital treatment in the past year and had a lifetime history of injection drug use (IDU). We evaluated the association between unhealthy alcohol use (AUDIT score > 7 [both hazardous drinking and dependence]), past-month injection drug use (IDU), and opioid craving (visual analogue scale from 1 to 100) with HIV care cascade outcomes. The primary outcome was linkage to HIV care within 12 months. Other outcomes were prescription of ART (secondary) and achievement of undetectable HIV viral load (HVL < 500 copies/mL) within 12 months (exploratory); the latter was analyzed on a subset in which HVL was measured (n = 48). We assessed outcomes via medical record review (linkage, ART) and serum tests (HVL). To examine the primary outcome, we used multiple logistic regression models controlling for potential confounders., Results: Among 249 study participants, unhealthy alcohol use (n = 148 [59%]) and past-month IDU (n = 130 [52%]) were common. The mean opioid craving score was 49 (SD: 38). We were unable to detect significant associations between the independent variables (i.e., unhealthy alcohol use, IDU and opioid craving) and any HIV care cascade outcomes in unadjusted and adjusted analyses., Conclusion: In this cohort of HIV-positive Russians with a history of IDU, individual substance use factors were not significantly associated with achieving HIV care cascade milestones (i.e., linkage to HIV care; prescription for ART; or suppressed viral load). Given no detection of an association of cascade outcomes with recent unhealthy use of alcohol or injection drugs in this cohort, examining systemic factors to understand determinants of HIV care engagement for people with drug use would be important.
- Published
- 2017
- Full Text
- View/download PDF
9. HIV Stigma and Unhealthy Alcohol Use Among People Living with HIV in Russia.
- Author
-
Lunze K, Lioznov D, Cheng DM, Nikitin RV, Coleman SM, Bridden C, Blokhina E, Krupitsky E, and Samet JH
- Subjects
- Adult, Alcohol Drinking psychology, Alcoholism complications, Alcoholism ethnology, Female, HIV Infections diagnosis, HIV Infections ethnology, Humans, Longitudinal Studies, Male, Middle Aged, Prevalence, Russia epidemiology, White People, Alcohol Drinking adverse effects, Alcoholism psychology, Discrimination, Psychological, HIV Infections psychology, Social Stigma
- Abstract
Unhealthy alcohol use, highly prevalent in the Russian Federation (Russia), is associated with HIV risk behaviors among people living with HIV (PLWH). HIV stigma contributes to the HIV risk environment in Russia. To examine HIV stigma among Russian PLWH and to explore its association with unhealthy alcohol use, we conducted a longitudinal analysis of 700 PLWH in St. Petersburg, Russia. We assessed the association between alcohol dependence and HIV stigma measured at baseline and 12 months follow-up. Participants with alcohol dependence (n = 446) reported significantly higher HIV stigma scores over time than those without dependence (n = 254) (adjusted mean difference 0.60, 95% CI 0.03-1.17; p = 0.04). In secondary analyses, we examined recent risky alcohol use and did not detect an association with HIV stigma. Alcohol dependence is associated with high HIV stigma among Russian PLWH but the nature of the association is conjectural. HIV prevention efforts in Russia that address alcohol use disorders hold potential to mitigate HIV-related stigma and its possible adverse effects among PLWH.
- Published
- 2017
- Full Text
- View/download PDF
10. Risk factors for recent nonfatal overdose among HIV-infected Russians who inject drugs.
- Author
-
Walley AY, Cheng DM, Coleman SM, Krupitsky E, Raj A, Blokhina E, Bridden C, Chaisson CE, Lira MC, and Samet JH
- Subjects
- Adult, Alcoholism prevention & control, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Confidence Intervals, Cross-Sectional Studies, Drug Overdose prevention & control, Female, Humans, Male, Odds Ratio, Risk Factors, Russia epidemiology, Self Disclosure, Substance Abuse, Intravenous prevention & control, Alcoholism epidemiology, Drug Overdose epidemiology, HIV Infections psychology, Risk-Taking, Substance Abuse, Intravenous epidemiology
- Abstract
Overdoses and HIV infection are common among Russians who inject drugs, yet risk factors have not been studied. We analyzed baseline data of 294 participants with 30-day injection drug use from an HIV secondary prevention trial for persons reporting "heavy" alcohol use (National Institute on Alcohol Abuse and Alcoholism [NIAAA] risky drinking definition) and risky sex in the past 6 months. The outcome was any self-reported overdose in the previous 3 months. We examined demographic, HIV-related, criminal justice, mental health, substance use, and injection risk factors. Participants' characteristics included median age 29 years, 117/294 (40%) female, and median CD4 cell count 345/µl. Over three quarters 223/294 (76%) reported a history of overdose and 47/294 (16%) reported overdose in the past 3 months. Past month injection frequency (adjusted odds ratio [AOR] 4.77, 95% confidence interval [CI]: 1.63-14.0 highest vs. lowest quartile; AOR 3.58, 95% CI: 1.20-10.69 second highest vs. lowest quartile) and anti-retroviral therapy (ART) at time of interview (AOR 3.96 95% CI: 1.33-11.83) were associated with 3-month overdose. Nonfatal overdose among HIV-infected Russians who inject drugs is common. Risk factors include injection frequency and anti-retroviral therapy (ART), which warrant further study. Overdose prevention efforts are needed among HIV-infected Russians who inject drugs.
- Published
- 2014
- Full Text
- View/download PDF
11. Pain is associated with heroin use over time in HIV-infected Russian drinkers.
- Author
-
Tsui JI, Cheng DM, Coleman SM, Blokhina E, Bridden C, Krupitsky E, and Samet JH
- Subjects
- Adult, Alcoholism complications, Cannabis, Central Nervous System Stimulants administration & dosage, Female, HIV Infections complications, Heroin Dependence complications, Humans, Longitudinal Studies, Male, Pain complications, Risk Factors, Russia epidemiology, Substance-Related Disorders complications, Substance-Related Disorders epidemiology, Alcohol Drinking epidemiology, Alcoholism epidemiology, HIV Infections epidemiology, Heroin Dependence epidemiology, Pain epidemiology
- Abstract
Aims: To evaluate whether pain was associated with increased risk of using heroin, stimulants or cannabis among HIV-infected drinkers in Russia., Design: Secondary analysis of longitudinal data from the HERMITAGE study (HIV's Evolution in Russia-Mitigating Infection Transmission and Alcoholism in a Growing Epidemic), a behavioral randomized controlled trial, with data collected at baseline, 6-month and 12-month visits., Setting: Recruitment occurred at HIV and addiction treatment sites in St Petersburg, Russian Federation., Participants: Six hundred and ninety-nine HIV-infected adult drinkers., Measurements: The primary outcome was past month illicit drug use; secondary outcomes examined each drug (heroin, stimulants and cannabis) separately. The main predictor was pain that interfered at least moderately with daily living. General estimating equations (GEE) logistic regression models were used to evaluate the association between pain and subsequent illicit drug use, adjusting for potential confounders., Findings: Participants reporting pain appeared to have higher odds of using illicit drugs, although the results did not reach statistical significance [adjusted odds ratio (OR) = 1.32; 95% confidence interval (CI) = 0.99, 1.76, P = 0.06]. There was a significant association between pain and heroin use (OR = 1.54; 95% CI = 1.11-2.15, P = 0.01) but not use of other drugs (OR = 0.75; 95% CI =0.40-1.40, P = 0.35 for stimulants and OR = 0.70; 95% CI = 0.45-1.07, P = 0.09 for cannabis)., Conclusions: HIV-infected Russian drinkers who report pain are more likely to use heroin over time than HIV-infected Russian drinkers who do not report pain. Pain may be an unrecognized risk factor for persistent heroin use with implications for HIV transmission in Russia., (© 2013 Society for the Study of Addiction.)
- Published
- 2013
- Full Text
- View/download PDF
12. Nondisclosure of HIV infection to sex partners and alcohol's role: a Russian experience.
- Author
-
Lunze K, Cheng DM, Quinn E, Krupitsky E, Raj A, Walley AY, Bridden C, Chaisson C, Lioznov D, Blokhina E, and Samet JH
- Subjects
- Adult, Cross-Sectional Studies, Female, HIV Infections epidemiology, Humans, Interviews as Topic, Logistic Models, Male, Middle Aged, Randomized Controlled Trials as Topic, Russia epidemiology, Self Disclosure, Socioeconomic Factors, Surveys and Questionnaires, Urban Population, Young Adult, Alcohol Drinking adverse effects, Alcohol Drinking epidemiology, Alcoholism epidemiology, HIV Infections transmission, Risk-Taking, Sexual Partners psychology, Truth Disclosure, Unsafe Sex
- Abstract
Nondisclosure of one's HIV infection to sexual partners obviates safer sex negotiations and thus jeopardizes HIV transmission prevention. The role of alcohol use in the disclosure decision process is largely unexplored. This study assessed the association between alcohol use and recent nondisclosure of HIV serostatus to sex partners by HIV-infected risky drinkers in St. Petersburg, Russia. Approximately half (317/605; 52.4 %) reported not having disclosed their HIV serostatus to all partners since awareness of infection. Using three separate GEE logistic regression models, we found no significant association between alcohol dependence, risky alcohol use (past 30 days), or alcohol use at time of sex (past 30 days) with recent (past 3 months) nondisclosure (AOR [95 % CI] 0.81 [0.55, 1.20], 1.31 [0.79, 2.17], 0.75 [0.54, 1.05], respectively). Alcohol use at time of sex was associated with decreased odds of recent nondisclosure among seroconcordant partners and among casual partners. Factors associated with nondisclosure were relationship with a casual partner, a serodiscordant partner, multiple sex partners, awareness of HIV diagnosis less than 1 year, and a lifetime history of sexually transmitted disease. Nondisclosure of HIV status to sex partners is common among HIV-infected Russians, however alcohol does not appear to be a predictor of recent disclosure.
- Published
- 2013
- Full Text
- View/download PDF
13. Associations between partner violence perpetration and history of STI among HIV-infected substance using men in Russia.
- Author
-
Raj A, Kidd JD, Cheng DM, Coleman S, Bridden C, Blokhina EA, Krupitsky E, and Samet JH
- Subjects
- Adult, Cross-Sectional Studies, Female, HIV Infections epidemiology, HIV Infections transmission, Humans, Male, Middle Aged, Russia epidemiology, Sexual Partners, Violence statistics & numerical data, Alcoholism complications, Sexually Transmitted Diseases epidemiology, Spouse Abuse statistics & numerical data, Substance-Related Disorders complications
- Abstract
Studies document a significant association between victimization from intimate partner violence (IPV) and sexually transmitted infections (STIs) and HIV among substance using women in Russia and elsewhere, but no study has examined IPV perpetration and STI among Russian men or HIV-infected men in Eastern Europe. This study was designed to assess the association between lifetime history of IPV perpetration and STI (lifetime and current) among substance using HIV-infected men in Russia. Cross-sectional analyses were conducted with baseline data from 415 male participants enrolled in a randomized HIV intervention clinical trial [the HERMITAGE Study]. Participants were HIV-infected men reporting recent heavy alcohol use and unprotected sex in St. Petersburg, Russia. Baseline surveys assessed demographics, IPV perpetration, risk behaviors, and STI history. Current STI was assessed via blood testing for syphilis and urine testing for gonorrhea, Chlamydia and Trichomonas. Multiple logistic regression analyses were used to assess the association between history of IPV with lifetime and current STI. Participants were aged 20-57 years. Almost half of participants (46%) reported a history of IPV perpetration; 81% reported past 30-day binge alcohol use, and 43% reported past 30-day injection drug use. Past and current STI was 41% and 12%, respectively. Men reporting a history of IPV perpetration had significantly higher odds of reporting ever having an STI (AOR=1.6, 95% CI=1.1, 2.4) but lower odds of testing positive for a current STI (AOR=0.50, 95% CI=0.26, 0.96). These findings demonstrate that a history of male IPV perpetration is common in HIV-infected Russian men and associated with a history of STI. Programmatic work toward IPV prevention is needed in Russia and may be beneficial in mitigating STIs, but more research is needed to understand how and why the association between IPV and STI changes over time in this population.
- Published
- 2013
- Full Text
- View/download PDF
14. Efficacy of alcohol reduction interventions among people with HIV as evaluated by self-report and a phosphatidylethanol (PEth) outcome: protocol for a systematic review and individual participant data meta-analysis
- Author
-
Kane, Jeremy C, Allen, Isabel, Fatch, Robin, Scheffler, Aaron, Emenyonu, Nneka, Puryear, Sarah B, Chirayil, Priya, So-Armah, Kaku, Kahler, Christopher W, Magidson, Jessica F, Conroy, Amy A, Edelman, E Jennifer, Woolf-King, Sarah, Parry, Charles, Kiene, Susan M, Chamie, Gabriel, Adong, Julian, Go, Vivian F, Cook, Robert L, Muyindike, Winnie, Morojele, Neo, Blokhina, Elena, Krupitsky, Evgeny, Fiellin, David A, and Hahn, Judith A
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Substance Misuse ,Sexually Transmitted Infections ,Alcoholism ,Alcohol Use and Health ,Clinical Research ,Infectious Diseases ,Behavioral and Social Science ,Clinical Trials and Supportive Activities ,HIV/AIDS ,Health and social care services research ,3.1 Primary prevention interventions to modify behaviours or promote wellbeing ,8.4 Research design and methodologies (health services) ,Prevention of disease and conditions ,and promotion of well-being ,Mental health ,Cardiovascular ,Good Health and Well Being ,Humans ,Self Report ,Alcohol Drinking ,Glycerophospholipids ,Ethanol ,HIV Infections ,Systematic Reviews as Topic ,Meta-Analysis as Topic ,substance misuse ,HIV & AIDS ,clinical trials ,Clinical Sciences ,Public Health and Health Services ,Other Medical and Health Sciences ,Biomedical and clinical sciences ,Health sciences ,Psychology - Abstract
IntroductionUnhealthy alcohol use is associated with a range of adverse outcomes among people with HIV (PWH). Testing the efficacy and promoting the availability of effective interventions to address unhealthy alcohol use among PWH is thus a priority. Alcohol use outcomes in intervention studies are often measured by self-report alone, which can lead to spurious results due to information biases (eg, social desirability). Measuring alcohol outcomes objectively through biomarkers, such as phosphatidylethanol (PEth), in addition to self-report has potential to improve the validity of intervention studies. This protocol outlines the methods for a systematic review and individual participant data meta-analysis that will estimate the efficacy of interventions to reduce alcohol use as measured by a combined categorical self-report/PEth variable among PWH and compare these estimates to those generated when alcohol is measured by self-report or PEth alone.Methods and analysisWe will include randomised controlled trials that: (A) tested an alcohol intervention (behavioural and/or pharmacological), (B) enrolled participants 15 years or older with HIV; (C) included both PEth and self-report measurements, (D) completed data collection by 31 August 2023. We will contact principal investigators of eligible studies to inquire about their willingness to contribute data. The primary outcome variable will be a combined self-report/PEth alcohol categorical variable. Secondary outcomes will include PEth alone, self-report alone and HIV viral suppression. We will use a two-step meta-analysis and random effects modelling to estimate pooled treatment effects; I2 will be calculated to evaluate heterogeneity. Secondary and sensitivity analyses will explore treatment effects in adjusted models and within subgroups. Funnel plots will be used to explore publication bias.Ethics and disseminationThe study will be conducted with deidentified data from completed randomised controlled trials and will be considered exempt from additional ethical approval. Results will be disseminated through peer-reviewed publications and international scientific meetings.Prospero registration numberCRD42022373640.
- Published
- 2023
15. Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV.
- Author
-
Heeren, Timothy, Emenyonu, Nneka, Freiberg, Matthew, Winter, Michael, Kim, Theresa, Magane, Kara, Lloyd-Travaglini, Christine, Fatch, Robin, Bryant, Kendall, Forman, Leah, Rateau, Lindsey, Blokhina, Elena, Muyindike, Winnie, Gnatienko, Natalia, Samet, Jeffrey, Bertholet, Nicolas, Saitz, Richard, and Hahn, Judith
- Subjects
CD4 ,HIV ,alcohol use disorder ,viral suppression ,Female ,Humans ,Alcoholism ,HIV ,Cross-Sectional Studies ,HIV Infections ,CD4 Lymphocyte Count ,Uganda ,Viral Load - Abstract
BACKGROUND: Alcohol use has been linked to worse human immunodeficiency virus (HIV) immunologic/virologic outcomes, yet few studies have explored the effects of alcohol use disorder (AUD). This study assessed whether AUD severity is associated with HIV viral suppression and CD4 count in the three cohorts of the Uganda Russia Boston Alcohol Network for Alcohol Research Collaboration on HIV/AIDS (URBAN ARCH) Consortium. METHODS: People with HIV (PWH) in Uganda (n = 301), Russia (n = 400), and Boston (n = 251), selected in-part based on their alcohol use, were included in analyses. Logistic and linear regressions were used to assess the cross-sectional associations between AUD severity (number of DSM-5 diagnostic criteria) and (1) HIV viral suppression, and (2) CD4 count (cells/mm3 ) adjusting for covariates. Analyses were conducted separately by site. RESULTS: The proportion of females was 51% (Uganda), 34% (Russia), and 33% (Boston); mean age (SD) was 40.7 (9.6), 38.6 (6.3), and 52.1 (10.5), respectively. All participants in Uganda and all but 27% in Russia and 5% in Boston were on antiretroviral therapy. In Uganda, 32% met criteria for AUD, 92% in Russia, and 43% in Boston. The mean (SD) number of AUD criteria was 1.6 (2.4) in Uganda, 5.6 (3.3) in Russia, and 2.4 (3.1) in Boston. Most participants had HIV viral suppression (Uganda 92%, Russia 57%, Boston 87%); median (IQR) CD4 count was 673 (506, 866), 351 (201, 542), and 591 (387, 881), respectively. In adjusted models, there were no associations between AUD severity and HIV viral suppression: adjusted odds ratios (AOR) (95%CI) per 1 additional AUD criterion in Uganda was 1.08 (0.87, 1.33); Russia 0.98 (0.92, 1.04); and Boston 0.95 (0.84, 1.08) or CD4 count: mean difference (95%CI) per 1 additional criterion: 5.78 (-7.47, 19.03), -3.23 (-10.91, 4.44), and -8.18 (-24.72, 8.35), respectively. CONCLUSIONS: In three cohorts of PWH, AUD severity was not associated with HIV viral suppression or CD4 count. PWH with AUD in the current era of antiretroviral therapy can achieve virologic control.
- Published
- 2023
16. Heavy Alcohol Use Among Women and Men Living With HIV in Uganda, Russia, and the United States.
- Author
-
Gnatienko, Natalia, Calver, Katherine, Sullivan, Meg, Forman, Leah S, Heeren, Timothy, Blokhina, Elena, Emenyonu, Nneka, Ventura, Alicia S, Tsui, Judith I, Muyindike, Winnie R, Fatch, Robin, Ngabirano, Christine, Bridden, Carly, Bryant, Kendall, Bazzi, Angela R, and Hahn, Judith A
- Subjects
Humans ,HIV Infections ,Cohort Studies ,Alcohol Drinking ,Uganda ,United States ,Russia ,Female ,Male ,Infectious Diseases ,Alcoholism ,Alcohol Use and Health ,Clinical Research ,Clinical Trials and Supportive Activities ,HIV/AIDS ,Prevention ,Substance Misuse ,Aetiology ,2.3 Psychological ,social and economic factors ,Oral and gastrointestinal ,Good Health and Well Being ,Gender Equality ,Public Health and Health Services ,Psychology ,Substance Abuse - Abstract
ObjectiveWe examined whether gender is associated with heavy drinking in three cohorts of people living with HIV (PLWH) in Mbarara, Uganda; St. Petersburg, Russia; and Boston, Massachusetts.MethodWe conducted secondary analyses of baseline data collected from three cohorts in the Uganda Russia Boston Alcohol Network for Alcohol Research Collaboration on HIV/AIDS (URBAN ARCH) consortium. We used multiple logistic regression models to evaluate the association between gender and heavy drinking (defined in combination with self-report and phosphatidylethanol [PEth]) within each cohort.ResultsIn unadjusted logistic regression models, we found no significant association between gender and heavy drinking in Russia or Boston. In Uganda, women were less likely than men to engage in heavy drinking (odds ratio = 0.38, 95% CI [0.26, 0.58], p
- Published
- 2021
17. Alcohol Types and HIV Disease Progression Among HIV-Infected Drinkers Not Yet on Antiretroviral Therapy in Russia and Uganda
- Author
-
Asiimwe, Stephen B, Fatch, Robin, Patts, Gregory, Winter, Michael, Lloyd-Travaglini, Christine, Emenyonu, Nneka, Muyindike, Winnie, Kekibiina, Allen, Blokhina, Elena, Gnatienko, Natalia, Kruptisky, Evgeny, Cheng, Debbie M, Samet, Jeffrey H, and Hahn, Judith A
- Subjects
Public Health ,Health Sciences ,HIV/AIDS ,Infectious Diseases ,Alcoholism ,Alcohol Use and Health ,Substance Misuse ,Pediatric ,Oral and gastrointestinal ,Infection ,Good Health and Well Being ,Adult ,Alcohol Drinking ,Alcoholic Beverages ,Beer ,Disease Progression ,Female ,HIV Infections ,Humans ,Male ,Middle Aged ,RNA ,Viral ,Risk ,Russia ,Substance Abuse ,Intravenous ,Uganda ,Viral Load ,Wine ,Young Adult ,Alcohol types ,HIV-infected patients ,HIV-disease progression ,HIV viral load ,Public Health and Health Services ,Social Work ,Public health - Abstract
In HIV-infected drinkers, alcohol types more likely to cause inflammation could plausibly increase the risk of HIV disease progression. We therefore assessed the association between alcohol type and plasma HIV RNA level (HIV viral load) among HIV-infected drinkers not on antiretroviral therapy (ART) in Russia and Uganda. We analyzed the data of participants from cohorts in Russia and Uganda and assessed their HIV viral load at enrollment by the alcohol type predominantly consumed. We defined predominant alcohol type as the alcohol type contributing >50% of total alcohol consumption in the 1 month (Russia) or 3 months (Uganda) prior to enrollment. Using multiple linear regression, we compared log10 HIV viral load by predominant alcohol type, controlling for age, gender, socioeconomic status, total number of standard drinks, frequency of drinking ≥6 drinks/occasion, and in Russia, history of injection drug use. Most participants (99.2% of 261 in Russia and 98.9% of 352 in Uganda) predominantly drank one alcohol type. In Russia, we did not find evidence for differences in viral load levels between drinkers of fortified wine (n = 5) or hard liquor (n = 49), compared to drinkers of beer/low-ethanol-content cocktails (n = 163); however, wine/high-ethanol-content cocktail drinkers (n = 42) had higher mean log10 viral load than beer/low-ethanol-content cocktail drinkers (β = 0.38, 95% CI 0.07-0.69; p = 0.02). In Uganda, we did not find evidence for differences in viral load levels between drinkers of locally-brewed beer (n = 41), commercially-distilled spirits (n = 38), or locally-distilled spirits (n = 43), compared to drinkers of commercially-made beer (n = 218); however, wine drinkers (n = 8) had lower mean log10 HIV viral load (β = -0.65, 95% CI -1.36 to 0.07, p = 0.08), although this did not reach statistical significance. Among HIV-infected drinkers not yet on ART in Russia and Uganda, we observed an association between the alcohol type predominantly consumed and the HIV viral load level in the Russia sample. These exploratory results suggest that, in addition to total number of drinks and drinking patterns, alcohol type might be a dimension of alcohol use that merits examination in studies of HIV and alcohol related outcomes.
- Published
- 2017
18. HERMITAGE: HIV prevention RCT in Russia
- Author
-
Samet, Jeffrey H, Raj, Anita, Cheng, Debbie M, Blokhina, Elena, Bridden, Carly, Chaisson, Christine E, Walley, Alexander Y, Palfai, Tibor P, Quinn, Emily K, Zvartau, Edwin, Lioznov, Dmitry, and Krupitsky, Evgeny
- Subjects
Public Health ,Health Sciences ,Prevention ,Clinical Research ,Health Services ,Behavioral and Social Science ,Substance Misuse ,Clinical Trials and Supportive Activities ,Alcoholism ,Alcohol Use and Health ,Infectious Diseases ,HIV/AIDS ,Sexually Transmitted Infections ,3.1 Primary prevention interventions to modify behaviours or promote wellbeing ,Prevention of disease and conditions ,and promotion of well-being ,Infection ,Good Health and Well Being ,Adult ,Alcohol Drinking ,Condoms ,Female ,HIV Infections ,Humans ,Male ,Psychotherapy ,Risk Reduction Behavior ,Risk-Taking ,Russia ,Secondary Prevention ,Sexually Transmitted Diseases ,Single-Blind Method ,Treatment Outcome ,Unsafe Sex ,Healthy relationships ,HIV risk behaviors ,RCT ,Russian HIV ,STI ,substance users ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Substance Abuse ,Public health ,Clinical and health psychology - Abstract
AimsThis study assessed the effectiveness of HERMITAGE (HIV's Evolution in Russia-Mitigating Infection Transmission and Alcoholism in a Growing Epidemic), an adapted secondary HIV prevention intervention, compared with an attention control condition in decreasing sexually transmitted infections (STIs) and sex and drug risk behaviors among Russian HIV-infected heavy drinkers.DesignWe conducted a single-blinded, two-armed, randomized controlled trial with 12-month follow-up.SettingThe study was conducted in St Petersburg, Russia. Participants were recruited from four HIV and addiction clinical sites. The intervention was conducted at Botkin Infectious Disease Hospital.ParticipantsHIV-infected individuals with past 6-month risky sex and heavy alcohol consumption (n = 700) were randomized to the HERMITAGE intervention (n = 350) or an attention control condition (n = 350).InterventionA Healthy Relationships Intervention stressing disclosure of HIV serostatus and condom use, adapted for a Russian clinical setting with two individual sessions and three small group sessions.MeasurementsThe primary outcome was incident STI by laboratory test at 12-month follow-up. Secondary outcomes included change in unprotected sex and several alcohol and injection drug use (IDU) variables.FindingsParticipants had the following baseline characteristics: 59.3% male, mean age 30.1, 60.4% past year IDU, 15.4% prevalent STI and mean CD4 cell count 413.3/μl. Assessment occurred among 75 and 71% of participants at 6 and 12 months, respectively. STIs occurred in 20 subjects (8.1%) in the intervention group and 28 subjects (12.0%) in the control group at 12-month follow-up; logistic regression analyses found no significant difference between groups (adjusted odds ratio 0.63; 95% confidence interval = 0.34-1.18; P = 0.15). Both groups decreased unsafe behaviors, although no significant differences were found between groups.ConclusionsThe HERMITAGE HIV risk reduction intervention does not appear to reduce sexually transmitted infections and HIV risk behaviors in Russian HIV-infected heavy drinkers compared with attention controls.
- Published
- 2015
19. Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems.
- Author
-
Tsui, Judith I., Rossi, Sarah L., Cheng, Debbie M., Bendiks, Sally, Vetrova, Marina, Blokhina, Elena, Winter, Michael, Gnatienko, Natalia, Backonja, Miroslav, Bryant, Kendall, Krupitsky, Evgeny, and Samet, Jeffrey H.
- Subjects
NALTREXONE ,ALCOHOLISM ,HIV-positive persons ,GABAPENTIN ,PLACEBOS ,BRIEF Pain Inventory - Abstract
Background: To estimate the effects on pain of two medications (low-dose naltrexone and gabapentin) compared to placebo among people with HIV (PWH) with heavy alcohol use and chronic pain. Methods: We conducted a pilot, randomized, double-blinded, 3-arm study of PWH with chronic pain and past-year heavy alcohol use in 2021. Participants were recruited in St. Petersburg, Russia, and randomized to receive daily low-dose naltrexone (4.5mg), gabapentin (up to 1800mg), or placebo. The two primary outcomes were change in self-reported pain severity and pain interference measured with the Brief Pain Inventory from baseline to 8 weeks. Results: Participants (N = 45, 15 in each arm) had the following baseline characteristics: 64% male; age 41 years (SD±7); mean 2 (SD±4) heavy drinking days in the past month and mean pain severity and interference were 3.2 (SD±1) and 3.0 (SD±2), respectively. Pain severity decreased for all three arms. Mean differences in change in pain severity for gabapentin vs. placebo, and naltrexone vs. placebo were -0.27 (95% confidence interval [CI] -1.76, 1.23; p = 0.73) and 0.88 (95% CI -0.7, 2.46; p = 0.55), respectively. Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively. Conclusion: Neither gabapentin nor low-dose naltrexone appeared to improve pain more than placebo among PWH with chronic pain and past-year heavy alcohol use. Clinical trial registration: ClinicalTrials.gov (NCT4052139). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. The Hepatitis C Continuum of Care Among HIV-Positive Persons with Heavy Alcohol Use in St. Petersburg, Russia.
- Author
-
Corcorran, Maria A., Ludwig-Baron, Natasha, Cheng, Debbie M., Lioznov, Dmitry, Gnatienko, Natalia, Patts, Gregory, So-Armah, Kaku, Blokhina, Elena, Bendiks, Sally, Krupitsky, Evgeny, Samet, Jeffrey H., and Tsui, Judith I.
- Subjects
HEPATITIS C treatment ,HIV-positive persons ,ALCOHOLISM ,CONFIDENCE intervals ,SELF-evaluation ,HEPATITIS C ,CONTINUUM of care ,MIXED infections ,DISEASE prevalence ,QUESTIONNAIRES ,LONGITUDINAL method - Abstract
This study describes the self-reported prevalence of hepatitis C virus (HCV) coinfection and the HCV care continuum among persons enrolled in the St PETER HIV Study, a randomized controlled trial of medications for smoking and alcohol cessation in HIV-positive heavy drinkers and smokers in St. Petersburg, Russia. Baseline health questionnaire data were used to calculate proportions and 95% confidence intervals for self-reported steps along the HCV continuum of care. The cohort included 399 HIV-positive persons, of whom 387 [97.0% (95% CI 95.3–98.7%)] reported a prior HCV test and 315 [78.9% (95% CI 74.9–82.9%)] reported a prior diagnosis of HCV. Among those reporting a diagnosis of HCV, 43 [13.7% (95% CI 9.9–17.4%)] had received treatment for HCV, and 31 [9.8% (95% CI 6.6–13.1%)] had been cured. Despite frequent HCV testing in this HIV-positive Russian cohort, the proportion reporting prior effective HCV treatment was strikingly low. Increased efforts are needed to scale-up HCV treatment among HIV-positive Russians in St. Petersburg. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. HERMITAGE--a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers
- Author
-
Samet, Jeffrey H, Raj, Anita, Cheng, Debbie M, Blokhina, Elena, Bridden, Carly, Chaisson, Christine E, Walley, Alexander Y, Palfai, Tibor P, Quinn, Emily K, Zvartau, Edwin, Lioznov, Dmitry, and Krupitsky, Evgeny
- Subjects
Adult ,Male ,and promotion of well-being ,Alcohol Drinking ,Clinical Trials and Supportive Activities ,Sexually Transmitted Diseases ,HIV Infections ,Medical and Health Sciences ,Russia ,Condoms ,Alcohol Use and Health ,Substance Misuse ,Risk-Taking ,Clinical Research ,Behavioral and Social Science ,Secondary Prevention ,Humans ,Single-Blind Method ,Healthy relationships ,HIV risk behaviors ,Russian HIV ,Unsafe Sex ,Prevention ,Psychology and Cognitive Sciences ,Substance Abuse ,Health Services ,Prevention of disease and conditions ,Psychotherapy ,Alcoholism ,Treatment Outcome ,Infectious Diseases ,Good Health and Well Being ,substance users ,Sexually Transmitted Infections ,HIV/AIDS ,3.1 Primary prevention interventions to modify behaviours or promote wellbeing ,Female ,STI ,Infection ,Risk Reduction Behavior ,RCT - Abstract
AimsThis study assessed the effectiveness of HERMITAGE (HIV's Evolution in Russia-Mitigating Infection Transmission and Alcoholism in a Growing Epidemic), an adapted secondary HIV prevention intervention, compared with an attention control condition in decreasing sexually transmitted infections (STIs) and sex and drug risk behaviors among Russian HIV-infected heavy drinkers.DesignWe conducted a single-blinded, two-armed, randomized controlled trial with 12-month follow-up.SettingThe study was conducted in St Petersburg, Russia. Participants were recruited from four HIV and addiction clinical sites. The intervention was conducted at Botkin Infectious Disease Hospital.ParticipantsHIV-infected individuals with past 6-month risky sex and heavy alcohol consumption (n = 700) were randomized to the HERMITAGE intervention (n = 350) or an attention control condition (n = 350).InterventionA Healthy Relationships Intervention stressing disclosure of HIV serostatus and condom use, adapted for a Russian clinical setting with two individual sessions and three small group sessions.MeasurementsThe primary outcome was incident STI by laboratory test at 12-month follow-up. Secondary outcomes included change in unprotected sex and several alcohol and injection drug use (IDU) variables.FindingsParticipants had the following baseline characteristics: 59.3% male, mean age 30.1, 60.4% past year IDU, 15.4% prevalent STI and mean CD4 cell count 413.3/μl. Assessment occurred among 75 and 71% of participants at 6 and 12 months, respectively. STIs occurred in 20 subjects (8.1%) in the intervention group and 28 subjects (12.0%) in the control group at 12-month follow-up; logistic regression analyses found no significant difference between groups (adjusted odds ratio 0.63; 95% confidence interval = 0.34-1.18; P = 0.15). Both groups decreased unsafe behaviors, although no significant differences were found between groups.ConclusionsThe HERMITAGE HIV risk reduction intervention does not appear to reduce sexually transmitted infections and HIV risk behaviors in Russian HIV-infected heavy drinkers compared with attention controls.
- Published
- 2015
22. Association between alcohol use and inflammatory biomarkers over time among younger adults with HIV—The Russia ARCH Observational Study.
- Author
-
So-Armah, Kaku A., Cheng, Debbie M., Freiberg, Matthew S., Gnatienko, Natalia, Patts, Gregory, Ma, Yicheng, White, Laura, Blokhina, Elena, Lioznov, Dmitry, Doyle, Margaret F., Tracy, Russell P., Chichetto, Natalie, Bridden, Carly, Bryant, Kendall, Krupitsky, Evgeny, and Samet, Jeffrey H.
- Subjects
ALCOHOL drinking ,YOUNG adults ,ALCOHOLISM ,ALCOHOLIC beverages ,HEPATITIS C ,BIOMARKERS ,HIV - Abstract
Background: Biomarkers of monocyte activation (soluble CD14 [sCD14]), inflammation (interleukin-6 [IL-6]), and altered coagulation (D-dimer) are associated with increased mortality risk in people with HIV. The objective of the Russia Alcohol Research Collaboration on HIV/AIDS (ARCH) study was to evaluate the association between heavy alcohol use and inflammatory biomarkers over time. Methods: The study sought antiretroviral therapy naive participants with HIV (n = 350) and assessed them at baseline, 12 and 24 months. Linear mixed effects models were used to determine whether heavy drinking (self-report augmented by phosphatidylethanol [PEth], an alcohol biomarker) was longitudinally associated with IL-6, sCD14 and D-dimer adjusting for potential confounders (e.g., demographics, HIV factors, comorbid conditions). Results: Participants’ baseline characteristics were as follows: 71% male; mean age of 34 years; 87% self-reported hepatitis C; and 86% current smokers. Mean log
10 (HIV RNA) was 4.3 copies/mL. Heavy alcohol use, based on National Institute of Alcohol Abuse and Alcoholism risky drinking criteria and PEth (versus non-heavy alcohol use) was associated with higher sCD14 (adjusted mean difference 125 ng/mL [95% CI: 42, 209]), IL-6 (ratio of means 1.35 [95% CI: 1.17, 1.55] pg/mL), and D-dimer (ratio of means 1.20 [95% CI: 1.06, 1.37] ug/mL) across the two-year follow-up. Conclusion: Among HIV+ adults, current heavy alcohol use is associated with higher sCD14, IL-6 and D-dimer over time. Since these biomarkers are associated with mortality, interventions to mitigate effects of heavy drinking on these immune processes merit consideration. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
23. Depression and smoking characteristics among HIV-positive smokers in Russia: A cross-sectional study.
- Author
-
Lasser, Karen E., Lunze, Karsten, Cheng, Debbie M., Blokhina, Elena, Walley, Alexander Y., Tindle, Hilary A., Quinn, Emily, Gnatienko, Natalia, Krupitsky, Evgeny, and Samet, Jeffrey H.
- Subjects
MENTAL depression ,SMOKING ,HIV-positive persons ,CIGARETTE smokers ,SUBSTANCE-induced disorders - Abstract
Introduction: Globally, persons with HIV infection, depression and substance use disorders have a higher smoking prevalence and smoke more heavily than other populations. These associations have not been explored among Russian smokers with HIV infection and substance use disorders. The purpose of this study was to examine the relationship between the presence of depressive symptoms and smoking outcomes in an HIV-positive cohort of Russian smokers with a history of substance use disorders (alcohol and/or drug use disorders). Methods: We performed a cross-sectional secondary data analysis of a cohort of HIV-positive regular smokers with a history of substance use disorders recruited in St. Petersburg, Russia in 2012–2015. The primary outcome was heavy smoking, defined as smoking > 20 cigarettes per day. Nicotine dependence (moderate-very high) was a secondary outcome. The main independent variable was a high level of depressive symptoms in the past 7 days (defined as CES-D > = 24). We used multivariable logistic regression to examine associations between depressive symptoms and the outcomes, controlling for age, sex, education, income, running out of money for housing/food, injection drug use, and alcohol use measured by the AUDIT. Results: Among 309 regular smokers, 79 participants (25.6%) had high levels of depressive symptoms, and 65 participants (21.0%) were heavy smokers. High levels of depressive symptoms were not significantly associated with heavy smoking (adjusted odds ratio [aOR] 1.50, 95% CI 0.78–2.89) or with moderate-very high levels of nicotine dependence (aOR 1.35, 95% CI 0.75–2.41). Conclusions: This study did not detect an association between depressive symptoms and smoking outcomes among HIV-positive regular smokers in Russia. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
24. Pain is associated with risky drinking over time among HIV-infected persons in St. Petersburg, Russia.
- Author
-
Tsui, Judith I., Cheng, Debbie M., Coleman, Sharon M., Lira, Marlene C., Blokhina, Elena, Bridden, Carly, Krupitsky, Evgeny, and Samet, Jeffrey H.
- Subjects
- *
HIV-positive persons , *ALCOHOLISM , *PAIN , *SELF medication , *DISEASE prevalence , *LOGISTIC regression analysis - Abstract
Background Pain is highly prevalent among persons with HIV. Alcohol may be used to “self-medicate” pain. This study examined the association between pain and risky alcohol use over time in a cohort of HIV-infected Russian drinkers. Methods This secondary analysis utilized longitudinal data from a randomized trial of a behavioral intervention. Subjects included HIV-infected adults who reported past 6-month risky drinking and unprotected sex and were recruited from HIV and addiction treatment sites in St. Petersburg, Russia. The main independent variable was pain that at least moderately interfered with daily living. The primary outcome was past month risky drinking amounts based on NIAAA guidelines. General estimating equations (GEE) logistic regression models were used to calculate odds ratios and 95% confidence intervals for the association between pain and risky drinking over time (i.e., baseline, 6 and 12 months), adjusting for potential confounders. Results Baseline characteristics of participants ( n = 699) were mean age of 30 (SD ±5) years, 41% female, and 22% <9th grade education. Nearly one quarter (24%) had a CD4 cell count <200 cells/μl, and only 17% were on antiretroviral therapy. Nearly half (46%) reported at least moderate pain interference in the past month and 81% were drinking risky amounts. In adjusted longitudinal GEE models, pain was significantly associated with greater odds of reporting past month risky drinking (AOR = 1.34, 95% CI: 1.05–1.71, p value = 0.02). Conclusions Among a cohort of HIV-infected Russian drinkers, pain that at least moderately interfered with daily living was associated with higher odds of reporting risky drinking amounts over time. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.